Director dealings: Dechra chairman lowers stake

Dechra Pharmaceuticals chairman Tony Griffin sold 5,000 ordinary shares in the FTSE 250 listed drug maker.

Griffin, who joined Dechra back in 2016, got rid of the shares the day before at an average price of 2,115.37p each, for a total transaction value of £105,768.50, the company said in a statement.

Dechra told investors that same day that its trading performance in its first quarter had been in-line with management expectations.

The group reported continued year-on-year growth in both its EU pharmaceuticals and North America pharmaceuticals operations, as its shareholders gathered in London for the annual general meeting.

It said it was "confident" in achieving its expectations for the current financial year and in the continued out-performance of the markets in which it operated.

As of 1330 GMT, Dechra shares had ticked up 1.65% to 2,132p.

Top Director Buys

4d Pharma (DDDD)
Director name: Norwood,David Robert
Amount purchased: 20,000 @ 114.00p
Value: £22,800.00

Lightwaverf (LWRF)
Director name: Gamble,Barry
Amount purchased: 50,000 @ 6.50p
Value: £3,250.00

Top Director Sells

Dechra Pharmaceuticals (DPH)

Director name: Griffin ,Tony

Amount sold: 5,000 @ 2,115.37p

Value: £105,768.50